Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults with treatment resistant anxiety disorder who score ?10 on GAD-7 questionnaire and are willing to consent.
Exclusion criteria
Exclusion criteria: 1. Participants unwilling to provide consent 2. Participants with known history of drug allergy to bupivacaine, lidocaine or depot methylprednisolone 3. Recent myocardial infarction 4. Patients on anti-coagulants or dual anti-platelet drugs 5. Glaucoma 6. Severe COPD 7. Cardiac conduction block
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study will be to determine the effectiveness of Stellate Ganglion Block in reducing anxiety in patients with Treatment Resistant Anxiety Disorder as quantified by GAD-7 questionnaire at 4 weeks post treatment.Timepoint: At baseline At 4 weeks At 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| GAD-7 score at 12 weeks post treatmentTimepoint: 12 weeks post intervention;change in Hamilton Anxiety scale scoresTimepoint: Baseline 4 weeks post intervention 12 weeks post intervention;change in quality of lifeTimepoint: 4 weeks post intervention 12 weeks post intervention | — |
Countries
India
Contacts
Sri Madhusudan Sai Institute of Medical Sciences and Research